Proteomic insights into chronic anthracycline cardiotoxicity
- 1 May 2011
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 50 (5) , 849-862
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?Progress in Cardiovascular Diseases, 2010
- Modulation of Mitochondrial Proteome and Improved Mitochondrial Function by Biventricular Pacing of Dyssynchronous Failing HeartsCirculation: Cardiovascular Genetics, 2010
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell deathBritish Journal of Cancer, 2009
- A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasomeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Build it up-Tear it down: protein quality control in the cardiac sarcomereCardiovascular Research, 2008
- Desmin mediates TNF-α–induced aggregate formation and intercalated disk reorganization in heart failureJournal of Cell Biology, 2008
- Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanismCritical Care, 2008
- p53 targets identified by protein expression profilingProceedings of the National Academy of Sciences, 2007
- Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrationsJournal of Molecular and Cellular Cardiology, 2007
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004